Pharmaniaga inks local manufacturing deal with Sinovac Biotech


A health worker shows a vial of Sinovac Biotech’s Coronavac during the vaccination of Philippine military at the national headquarters of the Philippine Army in Fort Bonifacio, Taguig City, Metro Manila, Philippines, on Tuesday (March 2, 2021). - Reuters

KUALA LUMPUR: Pharmaniaga Bhd has signed a local manufacturing agreement with China's Sinovac Biotech Ltd's subsidiary for the purchase of ready-to-fill bulk product of Covid-19 vaccine.

The company said on Monday its unit Pharmaniaga Lifescience Sdn Bhd (PLS) and Sinovac Life Sciences Co. Ltd had entered into the agreement on March 12 for the manufacturing of the vaccine by PLS.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Budget 2027: Targeted incentives needed to attract regional institutional investors to Malaysian equities
Pioneer Heat makes positive ACE Market debut
Batik Air says it can bring aircraft in quickly to absorb domestic market demand if required
FBM KLCI rebounds from weak start after Fed rate hike
Ringgit opens slightly lower vs US dollar after hawkish FOMC outcome
Fed hikes rates, sees more tightening in search of 'timelier' drop in inflation
Trading ideas: AirAsia, PTT Synergy, Frontken, Crest Builder, EcoWorld Malaysia, YTL Power, Hextar Retail
China sets 2030 roadmap for AI manufacturing
Unbilled sales likely to bolster property sector
BoJ set to raise interest rates to 31-year high

Others Also Read